Penile Cancer Mortality in Brazil: Are We Making Progress?

被引:0
|
作者
Mourao, Thiago Camelo [1 ]
Beraldi, Artur Agostinho [2 ]
Fernandes, Gisele Aparecida [3 ]
Neto, Plinio Ramos Pinto [1 ]
Batista, Rafael Valente [4 ]
Nobre, Jayme Quirino Caon [1 ]
Curado, Maria Paula [3 ]
Zequi, Stenio de Cassio [1 ,5 ,6 ]
机构
[1] AC Camargo Canc Ctr, Fdn Antonio Prudente, Dept Urol, Sao Paulo, Brazil
[2] Hosp Santa Catarina, Dept Urol, Sao Paulo, Brazil
[3] AC Camargo Canc Ctr, Int Res Ctr, A, C Camargo Canc Ctr, Sao Paulo, Brazil
[4] Hosp Sao Camilo Pompeia, Dept Urol, Sao Paulo, Brazil
[5] Natl Inst Sci & Technol Oncogen & Therapeut Innova, Sao Paulo, Brazil
[6] Sao Paulo Fed Univ, Grad Sch, Dept Surg, Div Urol, Sao Paulo, Brazil
关键词
HUMAN-PAPILLOMAVIRUS; UNITED-STATES; DISPARITIES;
D O I
10.1200/GO.23.00303
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE This study aims to analyze the trends in mortality rates from penile cancer (PeC) and the treatment modalities adopted in Brazil over recent years. MATERIALS AND METHODS Death records for PeC cases (International Classification of Diseases, version 10 C60) and treatment modalities were extracted from the DATASUS database. A joinpoint regression analysis was conducted to examine the data. RESULTS A total of 7,848 deaths due to PeC were recorded in Brazil between 1996 and 2020. Increasing mortality trends were observed, with an average annual percentage change (AAPC) of 0.91 (0.6-1.2; P < .001). The North and Northeast regions had the highest age-standardized mortality rates (ASMRs) and AAPCs. From 2008 to 2020, the ASMR in the Northeast region remained stable, whereas the North region surpassed it. The Southeast region exhibited a significant downward trend, with an AAPC of -0.91 (-1.3 to -0.5; P < .001). Penile biopsies declined and were more frequent in the southeastern region. A total of 8,498 penile amputations were performed, with 39.4% and 29.1% conducted in the Southeast and Northeast regions, respectively. CONCLUSION Brazil has experienced increasing mortality trends in PeC over the past 2 decades. Low schooling, married, and young men from the North or Northeast regions represent the majority of deaths. Urgent efforts are needed to enhance the diagnosis and treatment of PeC to prevent and reduce mortality rates in the country.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Mesothelioma: Are we making progress?
    Kindler, HL
    Vogelzang, NJ
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 1 - 1
  • [42] THERAPEUTIC PROGRESS - REVIEW 38 - ARE WE MAKING PROGRESS IN THE TREATMENT OF PROSTATE-CANCER
    CARR, TW
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1990, 15 (04) : 247 - 255
  • [43] Are we making progress? Not in haematology!
    McGrath, P
    OMEGA-JOURNAL OF DEATH AND DYING, 2002, 45 (04) : 331 - 348
  • [44] Are we making progress in curing advanced cervical cancer-again?
    Lindegaard, Jacob Christian
    Petric, Primoz
    Tan, Li-Tee
    Hoskin, Peter
    Schmid, Maximilian P.
    Jurgenliemk-Schulz, Ina
    Mahantshetty, Umesh
    Kirisits, Christian
    Potter, Richard
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [45] Dendritic cells in cancer immunotherapy clinical trials: are we making progress?
    Butterfield, Lisa H.
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [46] GI SIDE EFFECTS OF CANCER TREATMENT: ARE WE MAKING ANY PROGRESS?
    Faisal, A.
    Baber, W.
    Rana, Z.
    Andreyev, J.
    GUT, 2019, 68 : A194 - A194
  • [47] Lung Cancer in Ireland 2010-2015-Are We Making Progress?
    Mcnamara, Aoife
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S513 - S513
  • [48] New Targeted Agents in Endometrial Cancer: Are We Really Making Progress?
    Rodriguez-Freixinos, Victor
    Karakasis, Katherine
    Oza, Amit M.
    CURRENT ONCOLOGY REPORTS, 2016, 18 (04) : 1 - 12
  • [49] ARE WE MAKING PROGRESS IN THE DRUG-TREATMENT OF LUNG-CANCER
    BENFIELD, GFA
    CULLEN, MH
    JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1986, 11 (03): : 147 - 158
  • [50] LUNG CANCER MDT ACTIVITY IN QUEENSLAND: ARE WE MAKING ANY PROGRESS?
    Guan, Tracey
    Colquist, Shoni
    Blake, Michael
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 146 - 146